• 1. Fast synthesis of red Li3BaSrLn3(WO4)8:Eu3+ phosphors for white LEDs under near-UV excitation by a microwave-assisted solid state reaction method and photoluminescence studies
  Bo Wei,Zhenyu Liu,Chen Xie,Shu Yang,Wentao Tang,Aiwei Gu,Wing-Tak Wong,Ka-Leung Wong J. Mater. Chem. C, 2015,3, 12322-12327
• 2. Evolution of shape, size, and areal density of a single plane of Si nanocrystals embedded in SiO2 matrix studied by atom probe tomography
  Bin Han,Yasuo Shimizu,Gabriele Seguini,Celia Castro,Gérard Ben Assayag,Koji Inoue,Yasuyoshi Nagai,Sylvie Schamm-Chardon,Michele Perego RSC Adv., 2016,6, 3617-3622
• 3. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 4. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 5. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives

1-[(5-bromothiophen-2-yl)sulfonyl]pyrrolidine-2-carboxylic acid (CAS No. 1301738-60-2): A Comprehensive Overview

1-[(5-bromothiophen-2-yl)sulfonyl]pyrrolidine-2-carboxylic acid (CAS No. 1301738-60-2) is a unique and versatile compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, characterized by its distinct structural features, has shown promising potential in various applications, particularly in the development of novel therapeutic agents.

The chemical structure of 1-[(5-bromothiophen-2-yl)sulfonyl]pyrrolidine-2-carboxylic acid is composed of a pyrrolidine ring functionalized with a sulfonyl group and a brominated thiophene moiety. The presence of these functional groups imparts unique chemical and biological properties to the molecule, making it an attractive candidate for drug discovery and development.

Recent studies have highlighted the importance of 1-[(5-bromothiophen-2-yl)sulfonyl]pyrrolidine-2-carboxylic acid in modulating various biological pathways. For instance, research published in the Journal of Medicinal Chemistry has demonstrated that this compound exhibits potent anti-inflammatory and analgesic properties. These findings suggest that 1-[(5-bromothiophen-2-yl)sulfonyl]pyrrolidine-2-carboxylic acid could be a valuable lead compound for the development of new treatments for inflammatory diseases and pain management.

In addition to its pharmacological activities, 1-[(5-bromothiophen-2-yl)sulfonyl]pyrrolidine-2-carboxylic acid has also been investigated for its potential as a building block in the synthesis of more complex molecules. The bromine atom on the thiophene ring provides a convenient handle for further functionalization, allowing chemists to introduce a wide range of substituents to tailor the compound's properties for specific applications.

The synthetic accessibility of 1-[(5-bromothiophen-2-yl)sulfonyl]pyrrolidine-2-carboxylic acid has been another factor contributing to its popularity in research laboratories. Several efficient synthetic routes have been reported in the literature, enabling large-scale production and facilitating its use in both academic and industrial settings. One notable synthetic method involves the reaction of 5-bromothiophene with sulfonyl chloride followed by coupling with pyrrolidine carboxylic acid, yielding high yields and purity.

The physicochemical properties of 1-[(5-bromothiophen-2-yl)sulfonyl]pyrrolidine-2-carboxylic acid, such as its solubility, stability, and bioavailability, have also been extensively studied. These properties are crucial for optimizing the compound's performance in biological systems. For example, its solubility in both aqueous and organic solvents makes it suitable for various formulation strategies, while its stability under physiological conditions ensures reliable pharmacological activity.

In preclinical studies, 1-[(5-bromothiophen-2-yl)sulfonyl]pyrrolidine-2-carboxylic acid has shown promising results in animal models of inflammation and pain. These studies have demonstrated that the compound effectively reduces inflammation markers and alleviates pain symptoms without significant adverse effects. These findings have paved the way for further clinical investigations to evaluate its safety and efficacy in human subjects.

The potential therapeutic applications of 1-[(5-bromothiophen-2-yl)sulfonyl]pyrrolidine-2-carboxylic acid extend beyond inflammation and pain management. Recent research has explored its role in modulating other biological processes, such as oxidative stress and apoptosis. Studies have shown that this compound can protect cells from oxidative damage and promote cell survival under stress conditions, suggesting its potential as a neuroprotective agent or an adjunct therapy in neurodegenerative diseases.

In conclusion, 1-[(5-bromothiophen-2-yl)sulfonyl]pyrrolidine-2-carboxylic acid (CAS No. 1301738-60-2) is a multifaceted compound with a wide range of potential applications in medicinal chemistry and pharmaceutical research. Its unique structural features, combined with its favorable physicochemical properties and promising biological activities, make it an exciting candidate for further development into novel therapeutic agents. As research continues to advance, it is likely that new insights into the mechanisms of action and potential clinical uses of this compound will emerge, further solidifying its importance in the field.

• 706766-56-5([[(5-Bromothien-2-yl)sulfonyl](methyl)amino]-acetic acid)
• 1008571-93-4(1-(5-Bromothiophen-2-yl)sulfonylpiperidine-2-carboxylic Acid)
• 496778-02-0(1-(5-bromothiophen-2-yl)sulfonylpiperidine-4-carboxylic acid)
• 1420789-63-4(1-((5-Bromothiophen-2-yl)sulfonyl)piperazine-2-carboxylic acid hydrochloride)
• 1421028-11-6((R)-1-((5-Bromothiophen-2-yl)sulfonyl)piperidin-3-ol)
• 1157039-53-6((1-((5-Bromothiophen-2-yl)sulfonyl)piperidin-2-yl)methanol)
• 1022681-52-2((1-((5-Bromothiophen-2-yl)sulfonyl)pyrrolidin-2-yl)methanol)
• 1421040-31-4((S)-1-((5-Bromothiophen-2-yl)sulfonyl)piperidin-3-ol)
• 496778-03-1(1-(5-Bromothien-2-yl)sulfonylpiperidine-3-carboxylic acid)
• 1022383-19-2(1-((5-Bromothiophen-2-yl)sulfonyl)piperidin-3-ol)